Search
Close this search box.

Radiosurgery for Refractory Pain

During this webinar, Dr. Eduardo Lovo will present the rational using radiosurgery for patients with drug refractory pain. He will focus on the patient selection, the definition of the targets and structures at risk, the dose to be delivered. He will share his radiosurgery experience with the CyberKnife® System.

Fireside Discussion: Prostate Radiotherapy Advances

Dr. Khoo, Clinical Oncologist, The Royal Marsden, London and Dr. Blacksburg, VP, Chief Medical Officer (AMS), Accuray during this webinar will discuss the highlights from the September prostate webinar series and share their expert perspective on the future advances in prostate Stereotactic Body Radiotherapy (SBRT) and hypofractionated treatments.

Robotic, Frameless Thalamotomies for Tremor

The webinar objective is to get the audience familiar with CyberKnife® frameless thalamotomy for tremor. Besta Institute team will share their experience on the patient selection, target definition, dose prescription, planning optimization and patient follow-up. 

September Series: Evidencing the Future – Prostate Radiotherapy Advances for Routine Practice

In September, during prostate cancer awareness month, the Accuray Exchange is hosting a special webinar series to highlight the growing evidence and advances in prostate Stereotactic body radiotherapy (SBRT) and hypofractionated treatments using CyberKnife®️, TomoTherapy®️ and Radixact®️ Systems.  In this series you will hear from leading experts from the field of prostate radiation oncology, sharing their […]

Introduction of Real-Time Motion Synchronization Technology on the Radixact® System

Stereotactic radiotherapy for lung cancer has seen an increase in the number of cases treated, especially in elderly patients. In addition, the indication for stereotactic body radiotherapy(SBRT) for oligometastatic cases is rapidly expanding, as well as an increasing number of SBRT treatments in the abdominal region. For SBRT in the abdominal region and lower lung field, measures against the respiratory motion are important. Synchrony® is a technology that enables tracking and irradiation of moving targets. It is expected to guarantee the dose to the moving tumor and reduce the irradiation volume of normal tissues. However, to provide safe and reliable treatment, it is necessary to understand the Synchrony mechanism and its characteristics.

User Resources

Accuray Insights